We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHF icon
1051
Schwab International Equity ETF
SCHF
$68.5B
$8.71M 0.01%
553,980
+418,976
+310% +$7.14M
MLPA icon
1052
Global X MLP ETF
MLPA
$2.29B
$8.67M 0.01%
235,168
-5,875
-2% -$238K
TIPX icon
1053
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$2.04B
$8.67M 0.01%
445,437
-141,316
-24% -$2.83M
GXO icon
1054
GXO Logistics
GXO
$5.37B
$8.66M 0.01%
200,244
-26,722
-12% -$1.48M
CLF icon
1055
Cleveland-Cliffs
CLF
$7.04B
$8.63M 0.01%
561,472
-213,202
-28% -$5.1M
EFT
1056
Eaton Vance Floating-Rate Income Trust
EFT
$289M
$8.61M 0.01%
730,949
+44,455
+6% +$554K
ALE
1057
DELISTED
Allete
ALE
$8.57M 0.01%
145,817
-560
-0.4% -$34.2K
AVLR
1058
DELISTED
Avalara, Inc.
AVLR
$8.56M 0.01%
121,228
+15,966
+15% +$1.31M
DT icon
1059
Dynatrace
DT
$14.4B
$8.55M 0.01%
216,856
+6,806
+3% +$271K
DLS icon
1060
WisdomTree International SmallCap Dividend Fund
DLS
$1.07B
$8.54M 0.01%
146,345
+16,665
+13% +$1.06M
ITCI
1061
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.54M 0.01%
149,600
+624
+0.4% +$35.4K
IR icon
1062
Ingersoll Rand
IR
$33B
$8.52M 0.01%
202,547
-46,233
-19% -$2.1M
NEA icon
1063
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
$8.49M 0.01%
722,776
-44,749
-6% -$545K
PFM icon
1064
Invesco Dividend Achievers ETF
PFM
$810M
$8.49M 0.01%
246,082
-3,432
-1% -$125K
IRDM icon
1065
Iridium Communications
IRDM
$5.2B
$8.47M 0.01%
225,455
-5,194
-2% -$194K
BKR icon
1066
Baker Hughes
BKR
$64.1B
$8.43M 0.01%
291,885
+55,011
+23% +$1.86M
EMGF icon
1067
iShares Emerging Markets Equity Factor ETF
EMGF
$1.87B
$8.41M 0.01%
195,858
+16,959
+9% +$774K
EELV icon
1068
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$424M
$8.39M 0.01%
360,790
+324,420
+892% +$8.05M
AR icon
1069
Antero Resources
AR
$11.6B
$8.39M 0.01%
273,696
+72,838
+36% +$2.66M
AJRD
1070
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$8.38M 0.01%
206,367
+483
+0.2% +$19.5K
FTV icon
1071
Fortive
FTV
$18.7B
$8.36M 0.01%
204,089
+24,668
+14% +$1.09M
AVB icon
1072
AvalonBay Communities
AVB
$26.2B
$8.36M 0.01%
43,039
-753
-2% -$163K
IYM icon
1073
iShares US Basic Materials ETF
IYM
$1.03B
$8.35M 0.01%
70,882
+24,794
+54% +$3.43M
IMTM icon
1074
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.28B
$8.34M 0.01%
278,510
-1,270
-0.5% -$41.2K
WAB icon
1075
Wabtec
WAB
$49.9B
$8.29M 0.01%
100,987
+12,147
+14% +$1.08M

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.